Coherus Oncology, Inc. (CHRS) Insider Trading

Name: Coherus Oncology, Inc. (CHRS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 9, 2026): Satvat Ali J. (Director): Grant/Award of 30,000 shares.

Get alerted when insiders trade CHRS

Email address

Loading company data...

Beta

Loading company details...

Beta